Due 7/1/18 7 p.m EST

4 slide PPT not including title and Reference Page  APA

Scholar-Practitioner Project: Create a Digital Dashboard

Without the usability features inherent in effective design, informatics systems may overwhelm a user with data. This portion of your Scholar-Practitioner Project requires that you put to use the informatics display techniques that are covered in this week’s Learning Resources.

To complete this week’s portion of your Scholar-Practitioner Project, create a mock-up screen of a “digital dashboard” for your disease surveillance system. Your text includes examples and ideas for such digital dashboards. Include a framework for the display of data based on the algorithm you designed previously (see note from professor on algorithm below), using appropriate graphics, symbols, and words. Use PowerPoint when choosing to create the screen. Additionally, you may choose to annotate the mock-up as appropriate.

Please save the mock-up in the following formats:

· PowerPoint file: Use “.ppt” extension

(NOTE FROMPROFESSOR ON LAST WEEK PAPER ON SURVEILLANCE ALGORITHM)This is a good start; you have provided a good description of your pathology of interest and the diagnostic algorithm used by the clinicians.  Remember, the idea of this SPP is to develop (try to) a biosurveillance system for your disease/condition of interest.  You have mentioned the algorithm and some covariates; however, you did not address the surveillance algorithm.  Algorithms used in surveillance usually involve decisions based on statistical analyses of data provided (not usually intended for a diagnosis).  Remember, that you do not want to evaluate a clinical intervention or the burden of a disease, the intention of your system is surveillance. Please address the issues marked on your paper.  I am looking forward to reading the next steps of your project 

The unapproved use of approved drugs, also called off-label use, with children is quite common. This is because pediatric dosage guidelines are typically unavailable since very few drugs have been specifically researched and tested with children.

When treating children, prescribers often adjust dosages approved for adults to accommodate a child’s weight. However, children are not just “smaller” adults. Adults and children process and respond to drugs differently in their absorption, distribution, metabolism, and excretion. Children even respond differently during stages from infancy to adolescence. This poses potential safety concerns when prescribing drugs to pediatric patients. As an advanced practice nurse, you have to be aware of safety implications of the off-label use of drugs with this patient group.

To prepare:

· Review the Bazzano et al. and Mayhew articles in the Learning Resources. Reflect on situations in which children should be prescribed drugs for off-label use.

· Think about strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Consider specific off-label drugs that you think require extra care and attention when used in pediatrics.

With these thoughts in mind:

Post an explanation of circumstances under which children should be prescribed drugs for off-label use. Then, describe strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Include descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.

This work should have Introduction and conclusion

– This work should have at 3 to 5current references (Year 2012 and up)

– Use at least 2 references from class Learning Resources

The following Resources are not acceptable:

1. Wikipedia

2. Cdc.gov- nonhealthcare professionals section

3. Webmd.com

4. Mayoclinic.com

Required Readings

Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.

• Review Chapter 4, “Principles      of Pharmacotherapy in Pediatrics” (pp. 53-63)
       This chapter explores concepts relating to drug selection, administration,      and interaction for pediatric patients. It also compares age-related      pharmacokinetic differences in children and adults.
• Chapter 17, “Ophthalmic      Disorders” (pp. 221-243)
       This chapter examines the causes, pathophysiology, diagnostic criteria,      and drug treatment for four ophthalmic disorders: blepharitis,      conjunctivitis, keratoconjunctivitis sicca, and glaucoma. It also explores      methods of monitoring patient response to treatment.
• Chapter 43,      “Attention-Deficit/Hyperactivity Disorder” (pp. 743-756)
       This chapter explains the process of diagnosing      Attention-Deficit/Hyperactivity Disorder (ADHD). It also identifies drugs      for treating patients with ADHD, including proper dosages, selected      adverse events, and special considerations for each drug.
• Chapter 51, “Immunizations”      (pp. 906-926)
       This chapter explores vaccines that are licensed for use in the United      States and provides a recommended vaccination schedule for pediatric      patients and adults.
• Chapter 52, “Smoking Cessation”      (pp. 927-943)
       This chapter examines clinical implications of smoking. It also covers      various approaches for aiding patients who are dependent on nicotine but      want to stop smoking.
• Chapter 54, “Weight Loss” (pp. 945-956)
       This chapter begins by reviewing patient factors that contribute to      obesity. It also examines drug therapy for initiating weight loss in      patients, as well as alternative non-drug treatments.

Bazzano, A. T, Mangione-Smith, R., Schonlau, M., Suttorp, M. J., & Brook, R. H. (2009). Off-label prescribing to children in the United States outpatient setting. Academic Pediatrics, 9(2), 81–88. 

This study examines the frequency of off-label prescribing to children and explores factors that impact off-label prescribing.

Mayhew, M. (2009). Off-label prescribing. The Journal for Nurse Practitioners, 5(2), 122–123. 

This article reviews the prevalence of off-label prescribing, including its benefits and risks. It also explores issues regarding the safety of off-label prescribing and when it is unavoidable.

Drugs.com. (2012). Retrieved from http://www.drugs.com/

This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.

Required Media

Laureate Education, Inc. (Executive Producer). (2012). Advanced pharmacology – Final course review. Baltimore, MD: Author. 

This media is an interactive final review covering course content.